ArticleMedicine2022

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.